(19)
(11)
EP 0 655 918 A1
(12)
(43)
Date of publication:
07.06.1995
Bulletin 1995/23
(21)
Application number:
93919464.0
(22)
Date of filing:
23.08.1993
(51)
International Patent Classification (IPC):
A61K
( . )
A61K
9/
14
( . )
A61K
31/
70
( . )
A61P
43/
00
( . )
A61K
9/
08
( . )
A61K
31/
195
( . )
A61P
35/
00
( . )
C07F
9/
22
( . )
(86)
International application number:
PCT/GB1993/001789
(87)
International publication number:
WO 1994/004159
(
03.03.1994
Gazette 1994/06)
(84)
Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
(30)
Priority:
24.08.1992
GB 19920017998
(71)
Applicant:
THE WELLCOME FOUNDATION LIMITED
London NW1 2BP (GB)
(72)
Inventors:
CHANDRASEKARAN, Bangaru
Durham, NC 27707 (US)
DUCH, David, Stanley
Cary, NC 27511 (US)
(74)
Representative:
Stott, Michael John, et al
The Wellcome Foundation Limited Group Patents & Agreements Langley Court
Beckenham Kent BR3 3BS
Beckenham Kent BR3 3BS (GB)
(54)
TREATMENT OF CANCER WITH AZT AND ALKYLATING OR INTERCALATING AGENTS